Omic is an AI-driven digital patient and multi-omics drug discovery platform for target identification, biomarker discovery, and generative compound screening.
Omic.ai is an AI-driven platform designed to accelerate drug discovery by leveraging biological superintelligence. It provides an AI scientist that can ideate, form and test hypotheses, build research tools, run iterative experiments, perform complex data analyses, and write journal-ready manuscripts. The platform is optimized for biological and chemical reasoning in drug discovery, achieving high accuracy on graduate-level scientific benchmarks. The platform offers autonomous agents that execute multi-step research from hypothesis to validation, conducting deep research, generating scientific analyses, and designing experiments. It supports the entire drug discovery and development pipeline, from target biology and chemistry to clinical development, regulatory strategy, and market access. Omic also provides digital patient models for predicting drug response and reducing clinical trial failures. Omic aims to make users productive across the organization, with hundreds of specialized AI agents operating in parallel across discovery, clinical development, and cross-functional operations. It offers solutions for pharma and biotech companies to address complex research problems and license AI-discovered assets in various therapeutic areas.
Integrations: Custom MCP integrations (Enterprise plan)
Platforms: Web
View full Omic profile on Tools-Radar | Browse Research tools | Alternatives to Omic
Tools-Radar is a free directory of 10,000+ AI tools — discover, compare, and choose the right AI software for your needs. Visit tools-radar.com